Curaevia: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Curaevia
Largest movements
- Receivables within one year -€36,316
down €36,316 (-98.7%), from €36,782 to €466
of which Trade receivables: -€35,910
- Cash +€9,842
up €9,842 (+151.0%), from €6,518 to €16,360
mainly Receivables within one year (+€36,316) and Depreciation (+€7,951)
- Intangible fixed assets -€7,951
down €7,951 (-10.9%), from €72,626 to €64,675
- Trade debts -€36,010
down €36,010 (-96.2%), from €37,449 to €1,439
- Other debts +€1,387
up €1,387 (+2.9%), from €48,000 to €49,387
- Gross operating margin +€16,630
up €16,630, from -€7,510 to €9,121
- Depreciation +€3,591
up €3,591 (+82.4%), from €4,360 to €7,951
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €116,083 | €81,862 | -€34,221 | -29.5% |
| Fixed assets | 21/28 | €72,626 | €64,675 | -€7,951 | -10.9% |
| Intangible fixed assets | 21 | €72,626 | €64,675 | -€7,951 | -10.9% |
| Current assets | 29/58 | €43,457 | €17,187 | -€26,270 | -60.5% |
| Amounts receivable within one year | 40/41 | €36,782 | €466 | -€36,316 | -98.7% |
| Trade receivables | 40 | €35,910 | €0 | -€35,910 | -100.0% |
| Other amounts receivable | 41 | €872 | €466 | -€406 | -46.6% |
| Cash at bank and in hand | 54/58 | €6,518 | €16,360 | +€9,842 | +151.0% |
| Deferred charges and accrued income | 490/1 | €157 | €362 | +€204 | +130.1% |
| Total equity and liabilities | 10/49 | €116,083 | €81,862 | -€34,221 | -29.5% |
| Equity | 10/15 | €28,681 | €29,166 | +€485 | +1.7% |
| Contributions | 10/11 | €165,500 | €165,500 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€136,819 | -€136,334 | +€485 | +0.4% |
| Amounts payable | 17/49 | €87,402 | €52,696 | -€34,706 | -39.7% |
| Amounts payable within one year | 42/48 | €85,449 | €50,826 | -€34,623 | -40.5% |
| Trade debts | 44 | €37,449 | €1,439 | -€36,010 | -96.2% |
| Suppliers | 440/4 | €37,449 | €1,439 | -€36,010 | -96.2% |
| Other amounts payable | 47/48 | €48,000 | €49,387 | +€1,387 | +2.9% |
| Accrued charges and deferred income | 492/3 | €1,953 | €1,870 | -€83 | -4.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €4,360 | €7,951 | +€3,591 | +82.4% |
| Other operating charges | 640/8 | €516 | €528 | +€12 | +2.3% |
| Gross operating margin | 9900 | -€7,510 | €9,121 | +€16,630 | |
| Operating profit (loss) | 9901 | -€12,386 | €642 | +€13,028 | |
| Financial income | 75/76B | €0 | - | = | |
| Recurring financial income | 75 | €0 | - | = | |
| Financial charges | 65/66B | €148 | €157 | +€9 | +6.3% |
| Recurring financial charges | 65 | €148 | €157 | +€9 | +6.3% |
| Profit (loss) for the period before taxes | 9903 | -€12,533 | €485 | +€13,018 | |
| Profit (loss) for the period | 9904 | -€12,533 | €485 | +€13,018 | |
| Profit (loss) for the period to be appropriated | 9905 | -€12,533 | €485 | +€13,018 |
Source: filed annual accounts (NBB), fiscal years ended 31 March 2024 and 31 March 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.